mots c 5 amino 1mq MOTS-C 10MG/5-Amino 10MG NAD+ / MOTS-c / 5-Amino-1MQ

What does 5-Amino-1MQ do

Yes (strong) FDA status FDA-approved (T2D and obesity) Compound NAD+ (intravenous or subcutaneous) Mechanism Direct NAD+ supplementation Route IV infusion or subcutaneous Acts on appetite

GLP-1 agonists work primarily through appetite suppression and slower gastric emptying

NNMT activity is known to increase as aging progresses or in response to certain lifestyle factors, often resulting in a decline in metabolic efficiency and a buildup of stubborn fat

Any stack involving multiple experimental compounds increases the unknowns around safety and interactions

Whether that carries over to human blood sugar or waistlines is untested